Parcion Private Wealth LLC lessened its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 2.5% in the second quarter, Holdings Channel.com reports. The fund owned 25,928 shares of the exchange traded fund’s stock after selling 658 shares during the quarter. Parcion Private Wealth LLC’s holdings in SPDR S&P Biotech ETF were worth $2,404,000 at the end of the most recent quarter.
Other institutional investors have also recently bought and sold shares of the company. ICA Group Wealth Management LLC acquired a new position in shares of SPDR S&P Biotech ETF in the 4th quarter valued at $27,000. Scarborough Advisors LLC acquired a new position in shares of SPDR S&P Biotech ETF in the 4th quarter valued at $32,000. BOCHK Asset Management Ltd acquired a new position in shares of SPDR S&P Biotech ETF in the 4th quarter valued at $36,000. ORG Partners LLC acquired a new position in shares of SPDR S&P Biotech ETF in the 2nd quarter valued at $40,000. Finally, Vima LLC acquired a new position in shares of SPDR S&P Biotech ETF in the 4th quarter valued at $45,000.
SPDR S&P Biotech ETF Stock Down 1.6 %
XBI traded down $1.56 during trading on Friday, hitting $96.52. The company had a trading volume of 8,019,337 shares, compared to its average volume of 9,875,957. The company has a market capitalization of $7.36 billion, a PE ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a one year low of $63.80 and a one year high of $103.52. The firm’s 50-day moving average price is $97.74 and its 200 day moving average price is $93.80.
SPDR S&P Biotech ETF Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Read More
- Five stocks we like better than SPDR S&P Biotech ETF
- How to Use Stock Screeners to Find Stocks
- Is Merck Stock Undervalued After Its Colossal Earnings Growth?
- Options Trading – Understanding Strike Price
- Top 5 ETFs for Every Investor: From Semiconductors to Defense
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Blade Air Mobility: This Under-the-Radar Stock Could Double Soon
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.